Loading...
XSTO
BIOWKS
Market cap19mUSD
Dec 05, Last price  
2.37SEK
1D
2.60%
1Q
-23.30%
IPO
-76.60%
Name

Bio-Works Technologies AB

Chart & Performance

D1W1MN
XSTO:BIOWKS chart
P/E
—
P/S
7.32
EPS
—
Div Yield, %
—
Shrs. gr., 5y
20.95%
Rev. gr., 5y
35.51%
Revenues
25m
-41.99%
1,542,0003,677,0004,945,0006,563,0005,573,0007,234,00021,910,00041,320,00043,896,00025,465,000
Net income
-37m
L-34.25%
-12,361,000-17,157,000-23,657,000-37,955,000-42,113,000-44,549,000-12,942,000-44,950,000-56,821,000-37,357,000
CFO
-43m
L-26.82%
-13,123,000-14,457,000-21,232,000-34,689,000-40,041,000-43,359,000-13,369,000-39,880,000-58,990,000-43,168,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Bio-Works Technologies AB (publ), a biotechnology company, researches, develops, manufactures, and supplies agarose-based separation products to purify proteins, peptides, and other biomolecules primarily in Sweden. It offers activated and affinity resins; BabyBio columns; immobilized metal-ion affinity chromatography resins; ion exchange resins; OptioBio glass columns; screening kits; and size exclusion chromatography resins. The company's products are used in antibodies, his-tagged proteins, proteins, peptides, oligonucleotides, and viruses and vaccines applications. Bio-Works Technologies AB (publ) founded in 2006 and is headquartered in Uppsala, Sweden.
URL
https://www.bio-works.com
IPO date
Dec 14, 2017
Employees
48
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT